Trait Mindfulness and Personality Characteristics in a Microdosing ADHD Sample: a Naturalistic Prospective Survey Study

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2023 Nov 2

PMID 37915796

Authors

Eline C H M Haijen

Petra P M Hurks

Kim P C Kuypers

Affiliations

Soon will be listed here.

Abstract

Background: Microdosing (MD), repeatedly taking psychedelics in small, non-hallucinogenic amounts, has been practiced by individuals to relieve attention deficit hyperactivity disorder (ADHD) symptoms. Generally, adults diagnosed with ADHD have lower levels of mindfulness and differ in personality structure from non-ADHD adults. How MD affects mindfulness and personality in adults with ADHD remains unexplored.

Aim: This study aimed to investigate the effects of 4 weeks of MD on mindfulness and personality traits in adults diagnosed with ADHD and those experiencing severe ADHD symptoms. It was expected that mindfulness and the personality traits conscientiousness, extraversion, agreeableness, and openness would increase and neuroticism would decrease after 4 weeks of MD compared to baseline. It was explored if using conventional ADHD medication alongside MD and/or having comorbidities influenced MD-induced effects.

Methods: An online prospective naturalistic design was used to measure participants before MD initiation and 2 and 4 weeks later. Validated self-report measures were used assessing mindfulness (15-item Five Facet Mindfulness Questionnaire) and personality traits (10-item version of the Big Five Inventory) at three time points.

Results: The sample included = 233, = 66, and = 44 participants at the three time points, respectively. Trait mindfulness, specifically description and non-judging of inner experience, was increased, and neuroticism was decreased after 4 weeks of MD compared to baseline. The remaining personality traits remained unchanged. Using conventional medication and/or having comorbid diagnoses did not change the MD-induced effects on mindfulness and personality traits after 4 weeks.

Conclusion: MD induced changes in otherwise stable traits. Future placebo-controlled studies are warranted to confirm whether these changes occur in a controlled setting.

References

Kim H, Li N, Broyles A, Musoka L, Correa-Fernandez V . Validity of the 15-item five-facet mindfulness questionnaire among an ethnically diverse sample of university students. J Am Coll Health. 2021; 71(2):450-459. DOI: 10.1080/07448481.2021.1892700. View

Nigg J, John O, Blaskey L, Huang-Pollock C, Willcutt E, Hinshaw S . Big five dimensions and ADHD symptoms: links between personality traits and clinical symptoms. J Pers Soc Psychol. 2002; 83(2):451-469. DOI: 10.1037/0022-3514.83.2.451. View

Hartong V, van Emmerik A . Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study. J Psychoactive Drugs. 2022; 55(3):310-320. DOI: 10.1080/02791072.2022.2080616. View

Babyak M . What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004; 66(3):411-21. DOI: 10.1097/01.psy.0000127692.23278.a9. View

Li T, Mota N, Galesloot T, Bralten J, Buitelaar J, IntHout J . ADHD symptoms in the adult general population are associated with factors linked to ADHD in adult patients. Eur Neuropsychopharmacol. 2019; 29(10):1117-1126. DOI: 10.1016/j.euroneuro.2019.07.136. View

Baer R, Carmody J, Hunsinger M . Weekly change in mindfulness and perceived stress in a mindfulness-based stress reduction program. J Clin Psychol. 2012; 68(7):755-65. DOI: 10.1002/jclp.21865. View

Gomez R, Corr P . ADHD and personality: a meta-analytic review. Clin Psychol Rev. 2014; 34(5):376-88. DOI: 10.1016/j.cpr.2014.05.002. View

Krieger V, Amador-Campos J, Guardia-Olmos J . Executive functions, Personality traits and ADHD symptoms in adolescents: A mediation analysis. PLoS One. 2020; 15(5):e0232470. PMC: 7202790. DOI: 10.1371/journal.pone.0232470. View

Adler L, Faraone S, Spencer T, Michelson D, Reimherr F, Glatt S . The reliability and validity of self- and investigator ratings of ADHD in adults. J Atten Disord. 2007; 11(6):711-9. DOI: 10.1177/1087054707308503. View

10.

Johnstad P . Powerful substances in tiny amounts: An interview study of psychedelic microdosing. Nordisk Alkohol Nark. 2020; 35(1):39-51. PMC: 7434115. DOI: 10.1177/1455072517753339. View

11.

Rettenberger M, Klein V, Briken P . The Relationship Between Hypersexual Behavior, Sexual Excitation, Sexual Inhibition, and Personality Traits. Arch Sex Behav. 2015; 45(1):219-33. DOI: 10.1007/s10508-014-0399-7. View

12.

Kaertner L, Steinborn M, Kettner H, Spriggs M, Roseman L, Buchborn T . Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing. Sci Rep. 2021; 11(1):1941. PMC: 7820236. DOI: 10.1038/s41598-021-81446-7. View

13.

Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt D . Self-blinding citizen science to explore psychedelic microdosing. Elife. 2021; 10. PMC: 7925122. DOI: 10.7554/eLife.62878. View

14.

Jacob C, Romanos J, Dempfle A, Heine M, Windemuth-Kieselbach C, Kruse A . Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci. 2007; 257(6):309-17. DOI: 10.1007/s00406-007-0722-6. View

15.

Faraone S, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove M . The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021; 128:789-818. PMC: 8328933. DOI: 10.1016/j.neubiorev.2021.01.022. View

16.

Gu J, Strauss C, Crane C, Barnhofer T, Karl A, Cavanagh K . Examining the factor structure of the 39-item and 15-item versions of the Five Facet Mindfulness Questionnaire before and after mindfulness-based cognitive therapy for people with recurrent depression. Psychol Assess. 2016; 28(7):791-802. PMC: 4928699. DOI: 10.1037/pas0000263. View

17.

Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I . The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health. 2021; 11:04009. PMC: 7916320. DOI: 10.7189/jogh.11.04009. View

18.

Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K . Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology (Berl). 2019; 236(2):731-740. DOI: 10.1007/s00213-018-5106-2. View

19.

Fadiman J, Korb S . Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration. J Psychoactive Drugs. 2019; 51(2):118-122. DOI: 10.1080/02791072.2019.1593561. View

20.

Pelham 3rd W, Gonzalez O, Metcalf S, Whicker C, Scherer E, Witkiewitz K . Item Response Theory Analysis of the Five Facet Mindfulness Questionnaire and its Short Forms. Mindfulness (N Y). 2019; 10(8):1615-1628. PMC: 6823990. DOI: 10.1007/s12671-019-01105-x. View